In 2023, the share of corresponding/leading authors in biotechnology publications in France was at a certain level, as the data for years preceding 2024 is not provided. Forecasted figures from 2024 to 2028 suggest a minor decline from 84.07% to 83.17% in author dominance. The year-on-year decrease is subtle, maintaining a steady, albeit slight, decrease throughout the period. This implies a gradual shift potentially towards more collaborative authorship structures or shifts in publication conventions.
Future trends to monitor include changes in research collaboration dynamics, advancements in biotechnology that may lead to more shared authorship, and the influence of international collaborations on author share percentages.
